Lewatit® FO 36 is a macroporous, monodispersed, weakly basic, polystyrene-based ion exchange resin for the selective adsorption of oxoanions, such as arsenate or arsenite ions. It is doped with a nano-scale film of iron oxide covering the inner surfaces of the pores of the polymer bead. Target oxoanions are bonded by a specific, reversible reaction involving hydroxy-groups on the iron oxide surface.
Lewatit® FO 36 is especially suitable for use in the following applications:
In the purification of potable water arsenic can be removed down to rest concentrations significantly lower than 10 µ g/l which is the maximum contaminant level set in several countries. Lewatit® FO 36 is also capable of adsorbing other species such as HPO 4 2-, HSbO4 2-, SCN- etc.
Business Unit
Liquid Purification Technologies
Properties and benefits
Areas of Applications
How to use the product
When using Lewatit® FO 36 to treat potable water, special care should be paid at the onset. Please refer to the recommended start-up-conditions contained in this data sheet.
After pre-treatment as per instructions, Lewatit® FO 36 is in compliance with the European Resolution ResAP (2004)3
Synonyms
Ion Exchange Resin
2010-09-27
There will be a change in management at three of the 13 business units of specialty chemicals company LANXESS. Dr. Hans-Georg Schmitt, Head of the Basic Chemicals business unit (BAC), will retire as of January 1, 2011. Schmitt has been in charge of Basic Chemicals since the formation of LANXESS.
Dr. Hubert Fink (48), currently Head of the Semi-Crystalline Products business unit (SCP), will succeed Schmitt at the Basic Chemicals business unit at the turn of the year.
The successor to Dr. Fink as Head of the SCP business unit is Dr. Michael Zobel, MBA. He will assume his new role as of October 15, 2010. The 41-year-old is currently responsible for the LANXESS Ion Exchange Resins business unit (ION).
Dr. Zobel’s position as Head of ION will be taken over by Jean-Marc Vesselle (46) at the same time. Mr. Vesselle is currently responsible for the global product management and strategic development of the business unit.
LANXESS is a leading specialty chemicals company with sales of EUR 5.06 billion in 2009 and currently around 14,400 employees in 23 countries. The company is represented at 42 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of plastics, rubber, intermediates and specialty chemicals.